Categories: Business

It is important to make a vaccination strategy before Covid-19 vaccine, Kiran Mazumdar Shaw said this about the trial

Photo: BIOCON LTD

Draw Up Immunization Strategy for COVID-19 Vaccine, says Kiran Mazumdar-Shaw

new Delhi. Biotechnology industry stalwart Kiran Mazumdar Shaw said that whenever the vaccine of Kovid-19 comes, India should immediately devise its own vaccination strategy for vaccination of large population of the country. He said that if the government ensures that at least 20 percent of the population at the highest risk is vaccinated, then we can control the virus. Along with this, Majumdar Shaw also said that 20 percent of India's population means 20 to 30 crore people, which is a large number.

The executive chairman of Biocon Ltd said in an interview that it is difficult to make an accurate guess about the vaccine. However, from the end of this year to the middle of next year, it is expected to come. He said that some vaccine programs have started the third phase of clinical trials, while the first and second stages have mixed results. He said that nothing is sure about this and according to the report from America, every person will have to take two doses of vaccine, ie it will not be cheap.

He questioned whether the government would bear its cost? He said that in this regard, the perspective of the pharmaceutical economy and the defensive logic will have to be considered and a balance has to be made between the two. He said that a country of 130 billion people could not be vaccinated in such a short time and therefore epidemiologists would have to develop a model of how many people would be required to vaccinate initially.

He said that even though the companies producing the vaccine are going to make one billion doses, it cannot be done in a month. He said that you can make a maximum dose of eight to 10 crores per month. In such a situation, who will be the first 100 million people who will be given the vaccine. In this way we have to plan. Mazumdar-Shaw said that if India Biotech vaccine, or Zydus Cadila vaccine shows promising results, then we can start making the vaccine by the end of this year.

Regarding the corona virus infection, he said that the forecast is that it will be at its peak in different parts of the country in the next two-and-a-half months to four months. By the end of the year, it would have reached its peak in all parts of the country. He said that but after that people do not know about the next wave of infection and that is the real concern.

This post was published on July 21, 2020 11:40 am

Content Team

Recent Posts

fuel demand dips 11.7 percent in July

Photo: PTI Fuel demand dips new Delhi. After improving fuel demand in the country, once again it has softened. According…

Stock market ends in red on weak cues

Photo: GOOGLE stock market today new Delhi. The BSE Sensex ended the gains on Wednesday from the last four trading…

gold price down rs 1228 per 10 gram, silver fall Rs 5172 per kg

Photo: FILE gold and silver price today new Delhi. Gold and silver prices have seen a sharp drop today after…